Cargando…

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology

BACKGROUND: HPV DNA Array is an E1-targeting PCR genotyping test, with capability of distinguishing 18 high-risk (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) and 11 low-risk HPV types (6, 11, 40, 42, 44, 54, 67, 69, 70, 85, 97). HPV DNA Array uses multiplex PCR for E1-gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pesic, Aleksandra, Krings, Amrei, Hempel, Matthias, Preyer, Rosemarie, Chatzistamatiou, Kimon, Agorastos, Theodoros, Kaufmann, Andreas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651913/ https://www.ncbi.nlm.nih.gov/pubmed/31337408 http://dx.doi.org/10.1186/s12985-019-1197-6

Ejemplares similares

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Cobas 4800 HPV detection in cervical samples of Polish women
por: Smolarz, Beata, et al.
Publicado: (2019)

Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens
por: Martin, Isabella W., et al.
Publicado: (2012)

Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
por: Ki, Eun Young, et al.
Publicado: (2018)

Comparison of the Cobas 4800 HPV Test and the Seeplex HPV4A ACE with the Hybrid Capture 2 Test
por: Ki, Eun Young, et al.
Publicado: (2012)

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru
por: Iwasaki, Ricardo, et al.
Publicado: (2014)

Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece
por: Skroumpelos, Anastasios, et al.
Publicado: (2019)

High-Risk Human Papillomavirus Detection via Cobas(®) 4800 and REBA HPV-ID(®) Assays
por: Liewchalermwong, Sasiprapa, et al.
Publicado: (2022)

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media
por: Luo, Hongxue, et al.
Publicado: (2016)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
por: Cook, Darrel A., et al.
Publicado: (2015)

Comparative Performance of Anyplex II HPV28 and Cobas 4800 Human Papillomavirus (HPV) Assays for High-Risk HPV Detection in Self-collected Anal Samples
por: Delvallez, Gauthier, et al.
Publicado: (2023)

The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples
por: Duan, Lyufang, et al.
Publicado: (2020)

Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population
por: Liu, Stephanie S., et al.
Publicado: (2022)

Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test
por: Tranberg, Mette, et al.
Publicado: (2018)

A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results
por: Zhang, Yi, et al.
Publicado: (2023)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening
por: Hwang, Sang-Hyun, et al.
Publicado: (2018)

Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens
por: Cai, Xushan, et al.
Publicado: (2019)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
por: Bell, Margo, et al.
Publicado: (2023)

Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears
por: Jun, Sun-Young, et al.
Publicado: (2015)

HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
por: Frayle, Helena, et al.
Publicado: (2019)

Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa
por: Dreyer, Greta, et al.
Publicado: (2019)

HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas(®) HBV Test for Use on the Cobas(®) 4800 System
por: Ortonne, Valérie, et al.
Publicado: (2021)

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test
por: Polman, Nicole J, et al.
Publicado: (2017)

Correction: HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Dynamics of genotype-specific HPV clearance and reinfection in rural Ghana may compromise HPV screening approaches
por: Krings, Amrei, et al.
Publicado: (2019)

Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media
por: Jang, Dan, et al.
Publicado: (2021)

Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up
por: Lili, Eleftheria, et al.
Publicado: (2018)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
por: Bonde, Jesper, et al.
Publicado: (2019)

Evaluating HPV‐negative CIN2+ in the ATHENA trial
por: Petry, Karl Ulrich, et al.
Publicado: (2016)

Sputasol (Dithiothreitol 0.54%) Improves the Detection of Human Papillomaviruses Using the Cobas 4800 System
por: Wang, Qing-Yong, et al.
Publicado: (2017)

Application of the Cobas 4800 System for the Detection of High-Risk Human Papillomavirus in 5650 Asymptomatic Women
por: Wang, Shanyun, et al.
Publicado: (2020)

Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests
por: Tardif, Keith D., et al.
Publicado: (2016)

Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy
por: Nasioutziki, Maria, et al.
Publicado: (2020)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study
por: Gilbert, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vhvd0c7kgq1pj4j2hou2vduqk6